Combined HASPIN and mTOR inhibition is synergistic against KRAS-driven carcinomas

Xu, CY; Gao, QM; Wu, ZM; Lou, WJ; Li, XY; Wang, MH; Wang, NH; Li, QQ

Li, QQ (通讯作者),Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China.;Wang, NH (通讯作者),Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200040, Peoples R China.

TRANSLATIONAL ONCOLOGY, 2022; 26 ():

Abstract

Background: Oncogenic mutations in the KRAS gene are very common in human cancers, resulting in cells with well-characterized selective advantages. Fo......

Full Text Link